Department of Pediatrics and Medical Affairs, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Department of Medical Affairs-Performance Improvement, Cedars-Sinai Medical Center, Los Angeles, California, USA.
BMJ Qual Saf. 2014 Aug;23(8):690-7. doi: 10.1136/bmjqs-2014-003005. Epub 2014 Jun 9.
To sustainably reduce the rate of mislabelled laboratory specimens through implementation of a series of interventions as led and coordinated by a multidisciplinary performance improvement team.
The quality improvement project was performed at Cedars-Sinai Medical Center in Los Angeles, an academic care tertiary care hospital. Phlebotomy services are provided by unit-based nursing and dedicated laboratory-based phlebotomists. Baseline mislabelled specimen rate was obtained for a 6-month period prior to the first improvement intervention. Included in the rate of mislabelled specimens were inpatient blood and body fluid specimens. Anatomic pathology and cytological specimens and outpatient specimens were excluded. Mislabelled specimens were identified preanalytically, analytically or postanalytically. A specimen was considered mislabelled under the following circumstances: (1) specimen/requisition mismatch; (2) incorrect patient identifiers and (3) unlabelled specimen. Specimen mislabels were identified and validated monthly by a multidisciplinary team composed of personnel from nursing, laboratory and performance improvement. Performance improvement initiatives were implemented over a 2-year period with control charts used to assess improvement over time.
The rate of mislabelled specimens varied by clinical area and decreased significantly over a 24-month time period during the initiative from 4.39 per 10,000 specimens to 1.97 per 10,000 specimens. All clinical areas achieved a significant decrease in the rate of mislabelled specimens except for the operating room and labour and delivery.
A multidisciplinary unit specific approach using performance improvement methodologies focusing on human factors can reliably and sustainably reduce the rate of mislabelled laboratory specimens in a large tertiary care hospital.
通过实施一系列由多学科绩效改进团队领导和协调的干预措施,可持续降低实验室标本错误标签的发生率。
该质量改进项目在洛杉矶的雪松西奈医疗中心进行,这是一家学术护理三级保健医院。采血服务由基于单元的护理人员和专门的实验室采血人员提供。在第一次改进干预之前的 6 个月内,获得了错误标签标本的基线错误标签率。错误标签标本的发生率包括住院患者的血液和体液标本。排除了解剖病理学和细胞学标本以及门诊标本。错误标签标本在分析前、分析中和分析后被识别。以下情况下,标本被认为是错误标签的:(1)标本/申请不匹配;(2)不正确的患者标识符和(3)无标签的标本。标本错误标签由护理、实验室和绩效改进部门的多学科团队每月识别和验证。在 2 年的时间内实施了绩效改进措施,并使用控制图来评估随着时间的推移的改进情况。
错误标签标本的发生率因临床区域而异,在该倡议的 24 个月期间,从每 10000 个标本 4.39 个显著下降到每 10000 个标本 1.97 个。除了手术室和产房外,所有临床区域的错误标签标本发生率都显著下降。
使用以人为因素为重点的绩效改进方法的多学科特定方法可以可靠和持续地降低大型三级保健医院实验室标本错误标签的发生率。